Helping People With Alzheimer's Live Longer And Healthier Lives
Developing a Drug to Improve Quality of Life
Halo Mountain is developing a treatment for the 44 million people afflicted with Alzheimer's disease (AD). Leading scientists have demonstrated that the brain is damaged by inflammatory mediators which contribute to neurodegeneration in Alzheimer’s disease. The proposed treatment aims to therapeutically elevate uric acid availability in the CNS to protect cells from the AD-associated oxidative damage. Halo Mountain’s approach directly addresses the clinical need in Alzheimer’s disease for an effective early-stage treatment.